Search for: "Paul v. N. L. Industries, Inc." Results 41 - 60 of 77
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
23 Jan 2020, 10:37 pm by Schachtman
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
16 May 2012, 7:37 am by Rob Robinson
Compiled from online public domain resources, provided for your review/use is this week's update of key industry news, views, and events highlighting key electronic discovery related stories, developments, and announcements. [read post]
26 Dec 2016, 4:30 am by Ben
Well Marie-Andree cited that 1879 case  Feist Publications, Inc. v. [read post]
22 Apr 2014, 2:26 pm by Lyle Denniston
The over-the-air TV broadcasting industry’s lawyer, Washington attorney Paul D. [read post]
25 Feb 2023, 6:50 pm by admin
 Alice Hamilton, “Industrial Poisons,” 43 The American Federationist 707-13 (1936). 1937-04-26. [read post]
31 Jan 2019, 11:34 am by Schachtman
Eventually, the litigation industry, buoyed by its successes against asbestos-product manufacturers turned their attention to silica sand suppliers to foundries and other industrial users. [read post]
27 Dec 2014, 2:19 am by Ben
More from Europe: In Case C-355/12 Nintendo v PC Box the CJEU said that circumventing a protection system may not be unlawful. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ… [read post]